One can not automatically assume that a failure to show a difference in efficacy implies equally effective treatments. Those who fully read the article will know that the statistical analysis failed to show a difference between the two treatment arms; it does not assert that bevacizumab and ranibizumab are equally effective. The total sample size is insufficient to make a statement regarding which treatment is more effective. This is acknowledged in the article several times, particularly where limitations of the study are discussed.
![](https://freepngimg.com/download/social_media/63059-media-icons-telegram-twitter-blog-computer-social.png)
Stay updated, free articles. Join our Telegram channel
![](https://clinicalpub.com/wp-content/uploads/2023/09/256.png)
Full access? Get Clinical Tree
![](https://videdental.com/wp-content/uploads/2023/09/appstore.png)
![](https://videdental.com/wp-content/uploads/2023/09/google-play.png)